Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

On September 6, 2023 Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) reported that Chief Executive Officer Dr. Matt Coffey will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place September 11-13, 2023 at the Lotte New York Palace Hotel in New York, NY (Press release, Oncolytics Biotech, SEP 6, 2023, https://ir.oncolyticsbiotech.com/news/detail/608/oncolytics-biotech-to-participate-in-a-fireside-chat-at-the-h-c-wainwright-25th-annual-global-investment-conference [SID1234634946]). Additional details on the fireside chat can be found below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, September 12, 2023
Time: 9:30 a.m. ET
Location: Lotte New York Palace Hotel, Adams Room 4th Floor
Webcast Link: Available by clicking here

Company management will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright representative, or email [email protected].

A live webcast of the Company’s presentation will also be available on the Investor Relations page of Oncolytics’ website (LINK) and will be archived for three months.